{"id":5175,"date":"2020-12-01T17:52:01","date_gmt":"2020-12-01T16:52:01","guid":{"rendered":"https:\/\/staybletherapeutics.com\/sv\/?p=5175"},"modified":"2020-12-01T17:52:24","modified_gmt":"2020-12-01T16:52:24","slug":"inside-stayble-november-2020","status":"publish","type":"post","link":"https:\/\/staybletherapeutics.com\/sv\/presentationer\/inside-stayble-november-2020\/","title":{"rendered":"Inside Stayble: November 2020"},"content":{"rendered":"<p style=\"font-weight: 400;\">I\u00a0november\u00a02020 uppdateringen\u00a0f\u00f6rklarar\u00a0VD Andreas Gerward\u00a0den\u00a0kliniska fas IIb-studien med STA363\u00a0i mer detalj samt ger en \u00f6verblick av bolagets p\u00e5g\u00e5ende aktiviteter.<\/p>\n<p style=\"font-weight: 400;\">Inside Stayble \u00e4r en ny kommunikationskanal f\u00f6r att ge aktie\u00e4gare m\u00e5nadsvisa uppdateringar om Stayble Therapeutics och det kliniska utvecklingsprogrammet f\u00f6r STA363 i kronisk l\u00e4ndryggssm\u00e4rta.<\/p>\n<p style=\"font-weight: 400;\">Stayble \u00e4r listat p\u00e5 Nasdaq First North (STABL).<\/p>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>I\u00a0november\u00a02020 uppdateringen\u00a0f\u00f6rklarar\u00a0VD Andreas Gerward\u00a0den\u00a0kliniska fas IIb-studien med STA363\u00a0i mer detalj samt ger en \u00f6verblick av bolagets p\u00e5g\u00e5ende aktiviteter.<\/p>\n","protected":false},"author":1,"featured_media":5136,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[1],"tags":[],"_links":{"self":[{"href":"https:\/\/staybletherapeutics.com\/sv\/wp-json\/wp\/v2\/posts\/5175"}],"collection":[{"href":"https:\/\/staybletherapeutics.com\/sv\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/staybletherapeutics.com\/sv\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/staybletherapeutics.com\/sv\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/staybletherapeutics.com\/sv\/wp-json\/wp\/v2\/comments?post=5175"}],"version-history":[{"count":1,"href":"https:\/\/staybletherapeutics.com\/sv\/wp-json\/wp\/v2\/posts\/5175\/revisions"}],"predecessor-version":[{"id":5176,"href":"https:\/\/staybletherapeutics.com\/sv\/wp-json\/wp\/v2\/posts\/5175\/revisions\/5176"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/staybletherapeutics.com\/sv\/wp-json\/wp\/v2\/media\/5136"}],"wp:attachment":[{"href":"https:\/\/staybletherapeutics.com\/sv\/wp-json\/wp\/v2\/media?parent=5175"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/staybletherapeutics.com\/sv\/wp-json\/wp\/v2\/categories?post=5175"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/staybletherapeutics.com\/sv\/wp-json\/wp\/v2\/tags?post=5175"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}